BLOG
Life Sciences


The growing need for centralized content management

Written by Jason Arnsparger in Life Sciences on 19/12/17


Life sciences is a challenging sector to operate in. Competition is tough, and success requires a combination of business agility and control.

But although life sciences is subject to stringent and ever-changing regulation, it can have a tendency to manage content for international markets in an inefficient and error-prone way. 

Read more

Master data management and ISO IDMP standards

Written by Romuald Braun in Life Sciences on 23/11/17


Life sciences firms are used to an on-going stream regulatory hurdles, and the upcoming ISO IDMP compliance is another to add to the list. But ISO IDMP is also a little different, and promotes the kind of structure and discipline needed if organisations want to really break new ground and take their businesses forward.

How can organisations use ISO IDMP to change the way they operate, and to transform their master data management?

Read more

Glaswegian Hospitality Sets the Tone for A Successful ISPOR Glasgow Conference

Written by Dana Weiss in Life Sciences on 14/11/17


AMPLEXOR Life Sciences exhibited at the 20th Annual European Congress of ISPOR - The International Society for Pharmacoeconomic Research - in Glasgow, Scotland last week. The conference drew more than 4700 attendees from the health economics and outcomes research (HEOR) community with this year’s theme being “The Evolution of Value in Health Care”. Topics discussed included the evolution of Health Technology Assessments (HTAs), the use of Real-World Evidence (RWE) to Support Regulatory Approvals, and Reimbursement Systems Across Europe.
Read more

Labelling and Data Management: it’s all about the bigger picture

Written by Romuald Braun in Life Sciences on 20/09/17


For some firms in life sciences, product labelling is treated as a distinct, manually-driven process. This is a legacy of an era when technology was trusted and reliable than it is now, and it’s also a major error, as it can leave an organisation vulnerable to risk, such as costly product recalls, and inefficiency.

Read more

How Artificial Intelligence is impacting life sciences

Written by Elvis Paćelat in Life Sciences on 20/09/17


Artificial Intelligence (AI) is one of the most talked-about technologies of the last decade. It saw more deployment initially in other industries – telecoms and financial services (FS) were amongst the early adopters - but the past few years have seen a number of life sciences firms embrace AI and reap some of the benefits.

Read more

IDMP: A Big Data Challenge for European Pharma

Written by Andrew Marr in Life Sciences on 23/05/17


At this year’s AMPLEXOR “Be The Expert 2017” event, Pharm Exec spoke to Andrew Marr about the implications of the EU’s new IDMP (Identification of Medicinal Products) regulations for the pharmaceutical industry.

Read more

Life sciences set for the next stage of a technological revolution

Written by Sonja Vlašič in Life Sciences on 23/05/17


AMPLEXOR recently staged its 19TH annual life sciences conference, BE THE EXPERT 2017. Across three days of debate, discussion and presentations in Budapest, delegates learned more about some of the issues facing the life sciences industry in 2017 and also about some of the technological solutions that are available to address these issues. Elvis Paćelat, Vice President, Life Sciences, AMPLEXOR, gives an overview of what was discussed and where he feels the industry is heading.

Read more

Disrupt or be disrupted: Why the pressure is mounting for life sciences to take digital transformation seriously

Written by Elvis Paćelat in Life Sciences on 31/03/17


All life sciences organizations are under pressure to change. If the preventative healthcare and wellness trend doesn’t turn the industry upside down, it will be something else – from the need for more holistic remedies to the expectation of greater transparency.

Read more

Pursuing World Class RIM Part 4: Authoritative Source and Data Standards Update

Written by Steve Gens in Life Sciences on 03/01/17


Designation of specific RIM systems and repositories as the authoritative source for regulatory information has been the standard for many years as evidenced by our previous RIM research. In 2016 we took the next step towards understanding regulatory information authoritative sources by asking each company to assess their confidence in the data within the authoritative source for 10 essential capabilities.

Read more

Pursuing World Class RIM Part 3: Applying Emerging Technologies in the RIM Space

Written by Steve Gens in Life Sciences on 23/11/16


We have been discussing and anticipating the promise of emerging technology to significantly improve Regulatory Information Management (RIM) systems for the last few years. Historically traditional methods, such as more powerful servers and faster internal networks, shared workspaces and incremental software upgrades have provided relatively little business improvement.
Read more